HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidemi Nakagawa Selected Research

Neoplasm Metastasis (Metastasis)

1/2019Role of interleukin-24 in the tumor-suppressive effects of interferon-β on melanoma.
3/2017Case of desmoplastic melanoma with lung metastasis maintaining complete response after cessation of nivolumab.
7/2007Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidemi Nakagawa Research Topics

Disease

64Psoriasis (Pustulosis Palmaris et Plantaris)
03/2023 - 03/2002
18Psoriatic Arthritis
06/2020 - 07/2010
15Atopic Dermatitis (Atopic Eczema)
04/2023 - 11/2002
8Neoplasms (Cancer)
01/2019 - 02/2003
7Melanoma (Melanoma, Malignant)
01/2023 - 07/2007
6Eczema
10/2021 - 07/2014
6Infections
11/2017 - 05/2007
4Pruritus (Itching)
11/2020 - 01/2007
3Interstitial Lung Diseases (Interstitial Lung Disease)
06/2021 - 06/2016
3Neoplasm Metastasis (Metastasis)
01/2019 - 07/2007
3Inflammation (Inflammations)
12/2017 - 01/2016
3Exfoliative Dermatitis (Erythroderma)
05/2017 - 04/2011
3Skin Diseases (Skin Disease)
07/2016 - 11/2002
2Atrophy
02/2020 - 01/2006
2Obesity
01/2019 - 12/2014
2Arthralgia (Joint Pain)
03/2018 - 03/2012
2Rheumatoid Arthritis
12/2017 - 11/2013
2Arthritis (Polyarthritis)
12/2017 - 12/2017
2Pain (Aches)
11/2016 - 07/2010
2Joint Diseases (Joint Disease)
12/2015 - 01/2015
2Drug-Related Side Effects and Adverse Reactions
09/2013 - 09/2002
2Injection Site Reaction
03/2012 - 04/2010
2Merkel Cell Carcinoma
03/2010 - 11/2009
1Necrosis
06/2021
1Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
06/2020
1Telangiectasis (Telangiectasia)
02/2020
1Ankylosing Spondylitis
01/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2018
1Lymphoma (Lymphomas)
08/2018
1Skin Neoplasms (Skin Cancer)
08/2018
1Photoallergic Dermatitis (Photoallergy)
06/2018
1Phototoxic Dermatitis (Phototoxicity)
06/2018

Drug/Important Bio-Agent (IBA)

16Ustekinumab (CNTO 1275)FDA Link
03/2023 - 03/2012
16Adalimumab (Humira)FDA Link
03/2020 - 04/2010
13Monoclonal AntibodiesIBA
06/2021 - 04/2010
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021 - 08/2010
11Infliximab (Remicade)FDA Link
03/2020 - 07/2010
10Ointments (Pastes)IBA
04/2023 - 09/2002
7secukinumabIBA
04/2019 - 07/2014
6delgocitinibIBA
04/2023 - 06/2018
6Janus Kinase InhibitorsIBA
04/2023 - 06/2018
6Prostaglandins AIBA
06/2021 - 07/2010
6InterleukinsIBA
06/2021 - 08/2014
6Adrenal Cortex Hormones (Corticosteroids)IBA
07/2016 - 11/2002
5Immunoglobulin A (IgA)IBA
03/2023 - 02/2003
5AntibodiesIBA
03/2020 - 07/2002
5DNA (Deoxyribonucleic Acid)IBA
05/2015 - 05/2003
4Certolizumab PegolFDA Link
06/2022 - 04/2021
4Interleukin-12 (IL 12)IBA
03/2020 - 04/2003
4Interleukin-17 (Interleukin 17)IBA
03/2019 - 07/2014
4C-Reactive ProteinIBA
01/2019 - 07/2016
4Proteins (Proteins, Gene)FDA Link
01/2019 - 05/2003
4InterferonsIBA
01/2019 - 08/2015
4Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2017 - 02/2003
3brodalumabIBA
03/2021 - 01/2016
3EnzymesIBA
01/2019 - 02/2017
3IodineIBA
12/2017 - 07/2016
3AntigensIBA
02/2016 - 07/2002
3CytokinesIBA
12/2014 - 11/2002
2Immunoglobulins (Immunoglobulin)IBA
06/2021 - 02/2017
2tildrakizumabIBA
06/2021 - 06/2021
2Messenger RNA (mRNA)IBA
01/2019 - 02/2016
2ImmunosorbentsIBA
01/2019 - 01/2019
2OligonucleotidesIBA
01/2019 - 07/2007
2Biomarkers (Surrogate Marker)IBA
01/2019 - 10/2017
2guselkumabIBA
09/2018 - 05/2018
2Tacrolimus (Prograf)FDA LinkGeneric
08/2018 - 01/2006
2NivolumabIBA
03/2018 - 03/2017
2HLA-C Antigens (HLA-C)IBA
01/2018 - 03/2002
2Etanercept (Enbrel)FDA Link
12/2017 - 07/2014
2Cholecalciferol (Vitamin D3)FDA Link
07/2017 - 03/2016
2MucinsIBA
02/2017 - 05/2015
2Antinuclear AntibodiesIBA
04/2016 - 05/2015
2Therapeutic UsesIBA
09/2013 - 01/2006
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
04/2003 - 11/2002
21 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
11/2002 - 09/2002
1bimekizumabIBA
03/2023
1Neoplasm Antigens (Tumor Antigens)IBA
01/2023
1Peptides (Polypeptides)IBA
01/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1Biological FactorsIBA
06/2021
1betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric
11/2020
1calcipotriene (calcipotriol)FDA LinkGeneric
11/2020
1KHK4083IBA
08/2020
1Collagen Type VIIIBA
06/2020
1Interleukin-17 ReceptorsIBA
06/2020
1Lipocalin-2IBA
01/2019
1ametantrone (HAQ)IBA
01/2019
1interleukin-22 receptor (IL-22R)IBA
01/2019
1interleukin-24 (ST16)IBA
01/2019
1AdipokinesIBA
11/2018
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
08/2018
1Calcineurin InhibitorsIBA
08/2018
1Immunoglobulin E (IgE)IBA
06/2018
1Janus KinasesIBA
06/2018

Therapy/Procedure

19Therapeutics
01/2023 - 11/2002
3Biological Therapy
10/2017 - 08/2014
3Aftercare (After-Treatment)
01/2015 - 11/2013
1Intravenous Infusions
08/2020
1Retreatment
03/2019